It was concluded that the highland barley β-glucan could prevent NAFL due to suppressed ileal farnesoid X receptor (FXR) activity, unregulated hepatic gene expression of enzymes involved in BAs synthesis, and activated hepatic FXR signaling [41]. The gene discussed is NR1H4; the disease is non-alcoholic fatty liver.